logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Biotechnology
Filter

Biotechnology

Categories

Sectors

Locations

Exchange

NAI500

Our Newest Client Increased 229% in One Month! – This and Other Featured Opportunities on NAI500

Mar 4, 2019

Cannabis, Life Science

Aslan Out-Licenses Korean Rights for Oncology Drug in $13 Million Deal

Mar 1, 2019

Life Science

China Strengthens Clinical Trial Approval Rules for Cell and Gene Therapies

Mar 1, 2019

Life Science

Cutting in on an Entegris Deal, Merck KGaA Makes $5.9 Billion Bid for Versum

Feb 28, 2019

Life Science

Nanjing’s NJCTTQ Signs $4 Billion In-Licensing Deal for Bi-Specific Immunotherapies from Abpro

Feb 28, 2019

Life Science

Titan Medical Expands Global Intellectual Property Portfolio to 30 Patents Issued and 75 Pending with Receipt of First Patent in China

Feb 28, 2019

Life Science

Naturally Splendid Enterprises Ltd TSXV:NSP Biotechnology, Nutraceutical, Consumer Products and Services, 生物科技,营养品,消费品,

Naturally Splendid Issues Shares for Services

Feb 28, 2019

Life Science

WuXi Biologics Congratulates Amicus on Receiving FDA Breakthrough Therapy Designation for AT-GAA,药明生物合作伙伴Amicus新一代疗法获FDA突破性疗法认定

WuXi Biologics Congratulates Amicus on Receiving FDA Breakthrough Therapy Designation for AT-GAA

Feb 28, 2019

Life Science

Beijing Surgerii Completes A Round for Next-Gen Robotic Surgery Device

Feb 27, 2019

Life Science

Naturally Splendid Enterprises Ltd TSXV:NSP Biotechnology, Nutraceutical, Consumer Products and Services, 生物科技,营养品,消费品,

Naturally Splendid Announces $3,500,000 Non-Brokered Private Placement Facility Upgrades Increases Capacity to Meet Demand

Feb 27, 2019

Life Science

Bio-Techne Signs Strategic Cooperation Agreement with Lisen Imprinting Diagnostics

Feb 26, 2019

Life Science

CStone Pharma Completes $285 Million Hong Kong IPO; Trades Higher

Feb 26, 2019

Life Science

Shanghai Henlius’ Rituxan Biosimilar is First Biosimilar Approved in China

Feb 26, 2019

Life Science

Naturally Splendid Enterprises Ltd TSXV:NSP Biotechnology, Nutraceutical, Consumer Products and Services, 生物科技,营养品,消费品,

Naturally Splendid’s HempOmega(tm) Infused Beer Expands Distribution to Missouri

Feb 26, 2019

Life Science

Xynomic Starts Phase III Trial of HDAC Inhibitor in South Korea

Feb 25, 2019

Life Science

Gracell Biotech of Suzhou Completes $85 Million Series B for Immune Cell Gene Therapies

Feb 25, 2019

Life Science

Novartis gene therapy would be cost effective up to $900,000 -U.S. group,诺华基因疗法Zolgensma的成本效益惊人

Novartis gene therapy would be cost effective up to $900,000 -U.S. group

Feb 22, 2019

Life Science

PharmaEssentia and AOP Orphan Receive EU Approval of Besremi™ (Ropeginterferon Alfa-2b) for Treatment of Polycythemia Vera (PV) in EU

Feb 22, 2019

Life Science

  • ‹‹ Previous
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada